Such an unexpected type of tumor–host interaction, which leads to the systemic upregulation of BCRP, and very likely of other xenobiotic transporters too, has broad implications for cancer therapies, including chemotherapy and photodynamic therapy. Here, ABCG2 is linked to neoplasm.